Objective To determine treatment persistence and exacerbations in patients initiating inhaler
treatment with fixed-dose combinations of inhaled corticosteroids/long-acting beta-2 …

OBJECTIVE: To determine the persistence, exacerbations, and use of resources in patients
who use inhaler treatment with fluticasone propionate/formoterol (PF/Form) in relation with …

Background and objective Real‐world evidence suggests that persistence with inhaled
corticosteroids (ICS), the mainstay of asthma drug therapy, is generally poor. The effect of …

Background Although efficacy and safety of fluticasone furoate/vilanterol (FF/VI) and
budesonide/formoterol (BUD/F) have been demonstrated in clinical studies, real-world …

INTRODUCTION Asthma is a highly prevalent disease that often requires maintenance
therapy. Combined inhaled corticosteroid (ICS) and long‑acting β2‑agonist (LABA) inhalers …

Purpose To study persistence with inhaled corticosteroids (ICS) and its determinants in
asthma‐patients. Methods From the PHARMO database, asthma‐patients (age< 35 years) …

Background It is unclear whether patients with asthma benefit from stepping up to high-dose
inhaled corticosteroids (ICSs). Objective To determine the effectiveness of stepping up to …

BACKGROUND: It is unclear whether patients with asthma benefit from stepping up to high-
dose inhaled corticosteroids (ICSs). OBJECTIVE: To determine the effectiveness of stepping …

Introduction and objectives A retrospective cohort analysis was conducted comparing
persistence with, and adherence to, different inhaled corticosteroid/long-acting-β 2-agonist …

Importance Combined use of inhaled corticosteroids and long-acting β-agonists (LABAs) as
the controller and the quick relief therapy termedsingle maintenance and reliever therapy …